SK Life Science, Inc.
SK Life Science, Inc. (USA) holds 0 active US FDA Type II Drug Master Files and 1 inactive. 3 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “SK Life Science, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sk-life-science-inc
Overview
SK Life Science, Inc. is a subsidiary of SK Biopharmaceuticals, focused on developing therapies for neurological disorders. The company is committed to bringing innovative treatments to patients with unmet medical needs.
Therapeutic areas
API / Drug Master Files
SK Life Science, Inc. holds 0 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- CARISBAMAT (RWJ 333369)Inactive2008-10-22
FDA compliance signals
3 FDA enforcement records linked to this company.
- 4832021-08-11
Failure to report non-alert ADEs
- 4832021-08-11
Failure to develop written procedures
- 4832021-08-11
Late submission of 15-day report
Is this SK Life Science, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.